ARCHIVES

ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer

This article is from The Cancer Letter archive.

Vol. 24 No. 22 | June 5, 1998

Download PDF Visit The Full Archive

Related Articles

Cuts Claimed to Displace “Millions” of Patients Yet None Seem to Complain. Why Not?

April 25, 2013

DCCP Board Okays Concept Of Study On Black/White Survival Differences

March 5, 1982

NCI funds 17 EDRN biomarker labs. Bush signs omnibus funding legislation.

December 10, 2004

Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards

February 7, 1997

NIH Selects 16 Clinical Centers for Women’s Health Initiative

April 9, 1993

Prostate Cancer: NIH Pans To Ramp Up Prostate Cancer Research Funding

June 25, 1999